Waters Corporation (Milford, Massachusetts) entered into an agreement with the Chinese Pharmacopoeia Commission (ChP) to establish a joint open laboratory.
Waters Corporation (Milford, Massachusetts) entered into an agreement with the Chinese Pharmacopoeia Commission (ChP) to establish a joint open laboratory. Scheduled to open before the end of 2014, the laboratory will focus on in-depth research of pharmacopoeia standards, development of testing methods, method validation, and basic and advanced technical training of pharmacopoeia detection methods. Both the ChP and Waters expect the laboratory to become one of the national technical support centers in Chinese pharmaceutical standards.
The Joint Open Laboratory will be located in the laboratory building of Beijing Zhendong Guangming Drug Research Institute (Beijing, China) and will be more than 1300 square feet in size. It will be outfitted with Waters’ chromatography and mass spectrometry systems, including, but not limited to, a range of Acquity UPLC systems, Acquity UPC2 systems, Xevo tandem quadrupole and time-of-flight mass spectrometers, and a natural products application solution with UNIFI software.
Removing Double-Stranded RNA Impurities Using Chromatography
April 8th 2025Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how chromatography can be used to remove double-stranded RNA impurities during mRNA therapeutics production.
The Effect of Time and Tide On PFAS Concentrations in Estuaries
April 8th 2025Oliver Jones and Navneet Singh from RMIT University, Melbourne, Australia discuss a recent study they conducted to investigate the relationship between tidal cycles and PFAS concentrations in estuarine systems, and offer practical advice on the sample preparation and LC–MS/MS techniques they used to achieve the best results.